Skip to main content
OpenTrials

Clinical trial condition

Cholangitis, Sclerosing

Explore clinical trials studying Cholangitis, Sclerosing. Study availability and eligibility vary by location and protocol.

109 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Cholangitis, Sclerosing trial results

Active, not recruiting

CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)

NCT05896137

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Captail Medcial University Beijing, Beijing Municipality, China
  • Beijing YouAn Hostital, Captial Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View Trial Details
Active, not recruiting

Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)

NCT04133792

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Skåne Universitetssjukhus Malmö, Skåne County, Sweden
  • Norrlands Universitetssjukhus Umeå, Västerbotten County, Sweden
  • Sahlgrenska Universitetssjukhuset Gothenburg, Västra Götaland County, Sweden
  • Sahlgrenska Universitetssjukhuset Östra Gothenburg, Sweden
View Trial Details
Active, not recruiting

norUrsodeoxycholic Acid vs Placebo in PSC

NCT03872921

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Medical University of Vienna, Department of Internal Medicine III Vienna, Austria
  • Medical School Hannover Hanover, Lower Saxonia, Germany
View Trial Details
Completed

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

NCT03333928

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health Tuscon, Arizona, United States
  • Fresno Clinical Research Center Fresno, California, United States
  • Keck School of Medicine of USC Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions